Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $18.2 million.

  • Celularity's Operating Expenses fell 1267.35% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.1 million, marking a year-over-year increase of 3931.18%. This contributed to the annual value of $92.6 million for FY2024, which is 5695.21% down from last year.
  • According to the latest figures from Q3 2025, Celularity's Operating Expenses is $18.2 million, which was down 1267.35% from $21.6 million recorded in Q2 2025.
  • In the past 5 years, Celularity's Operating Expenses ranged from a high of $103.0 million in Q3 2023 and a low of -$13.4 million during Q4 2022
  • Moreover, its 5-year median value for Operating Expenses was $21.9 million (2025), whereas its average is $28.6 million.
  • As far as peak fluctuations go, Celularity's Operating Expenses soared by 3054259.75% in 2021, and later crashed by 16743.07% in 2022.
  • Celularity's Operating Expenses (Quarter) stood at $19.8 million in 2021, then tumbled by 167.43% to -$13.4 million in 2022, then surged by 90.99% to -$1.2 million in 2023, then skyrocketed by 2378.64% to $27.4 million in 2024, then crashed by 33.66% to $18.2 million in 2025.
  • Its Operating Expenses stands at $18.2 million for Q3 2025, versus $21.6 million for Q2 2025 and $21.9 million for Q1 2025.